You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metronomic therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally

Recruiting
  • to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
  • Capecitabine 500Mg Oral Tablet
  • Shanghai, China
    Eye & ENT Hospital, Fudan University
Jul 2, 2023

Recurrent Neuroblastoma Trial in Germany (metronomic therapy)

Recruiting
  • Recurrent Neuroblastoma
  • metronomic therapy
  • Bonn, Germany
  • +7 more
Nov 3, 2022

Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
  • Singapore, Singapore
  • +1 more
Oct 16, 2023

Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)

Recruiting
  • Breast Cancer
  • Capecitabine+endocrine therapy
  • Placebo+endocrine therapy
  • Zhengzhou, Henan, China
    Henan cancer hospital
Nov 19, 2022

Breast Cancer Trial in Guangzhou (Tucidinostat, Capecitabine, Endocrine Therapy)

Recruiting
  • Breast Cancer
  • Guangzhou, Gangdong, China
    Shusen Wang
Nov 1, 2022

Leiomyosarcoma Trial in Santa Monica (Trabectedin)

Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
    Sant P Chawla
Oct 13, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (PD-1 antibody, Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 17, 2022

Neuroblastoma Trial in Houston (Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN

Active, not recruiting
  • Neuroblastoma
  • Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
  • Cytoxan
  • Houston, Texas
    Texas Children's Hospital
Mar 25, 2022

Sarcoma Trial in Boston (Bevacizumab, Doxorubicin, Radiation Therapy)

Active, not recruiting
  • Sarcoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 6, 2022

Pancreatic Cancer Trial in Shanghai (Capecitabine)

Recruiting
  • Pancreatic Cancer
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
Apr 29, 2021

Colorectal Cancer Trial in Shanghai (Capecitabine)

Terminated
  • Colorectal Cancer
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
Apr 28, 2021

Breast Cancer Trial in Besançon (Letrozole, Anastrozole, Vinorelbine)

Terminated
  • Breast Cancer
  • Besançon, France
    CHU Besançon
Jan 29, 2021

Neuroendocrine Tumors, Gastro Entero Pancreatic Neuroendocrine Tumors Trial in Meldola, Milan (28 GBq 177Lu-DOTATATE, 22 GBq

Active, not recruiting
  • Neuroendocrine Tumors
  • Gastro Entero Pancreatic Neuroendocrine Tumors
  • 28 GBq 177Lu-DOTATATE
  • 22 GBq 177Lu-DOTATATE
  • Meldola, FC, Italy
  • +1 more
Feb 25, 2021

Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)

Recruiting
  • Glioma
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 22, 2021

Glioblastoma, Glioblastoma Multiforme, Gliosarcoma Trial run by the NCI (topotecan, pazopanib)

Completed
Has Results
  • Glioblastoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 3, 2020

Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)

Active, not recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
    State Key Laboratory of Oncology in South China, Sun Yat-sen Uni
Jan 27, 2023

Triple Negative Breast Cancer Trial in Guangzhou (Capecitabine, Tucidinostat)

Recruiting
  • Triple Negative Breast Cancer
  • Guangzhou, Guangdong, China
    Sun-yat sen university cancer center
Nov 1, 2022

ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal

Unknown status
  • Metastatic Breast Cancer
  • Hormonal therapy-based treatments
  • Taipei, Taiwan
  • +1 more
Jan 11, 2021

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Ewing's Sarcoma, Osteosarcoma, Astrocytoma Trial in Atlanta (sirolimus)

Completed
  • Ewing's Sarcoma
  • +15 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
May 27, 2020

EGFR, NSCLC, Third-generation TKI Trial (Almonertinib and metronomic oral vinorelbine)

Not yet recruiting
  • EGFR
  • +2 more
  • Almonertinib and metronomic oral vinorelbine
  • (no location specified)
Dec 21, 2022

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Wilms Tumor Trial in France (Vincristine, Irinotecan, Temozolomide)

Not yet recruiting
  • Wilms Tumor
  • Amiens, France
  • +11 more
May 18, 2022

Aggressive Non-Hodgkin Lymphoma Trial in Italy (Prednisone, Vinorelbine, Etoposide)

Completed
  • Aggressive Non-Hodgkin Lymphoma
  • Brescia, Italy
  • +9 more
Dec 17, 2021